Politics and Policy

From public furor over price hikes to the loss of patent protections for blockbuster drugs, big changes are afoot in the pharmaceutical marketplace. Read more.

Weighing the ethics of approving expensive cancer drugs for patients facing terminal disease is a multifaceted endeavor. Here are some recommendations.

Medical marijuana’s therapeutic evidence base remains nascent and controversial but the regulatory landscape is evolving rapidly.

On March 10, the White House announced that President Donald Trump selected Scott Gottlieb, MD, who has worked for FDA in the past, as his choice to head the FDA. Here are five things managed healthcare executives should know about the pick.

Our policy analyst weighs in on a new drug industry PR campaign that attempts to shift the blame for high drug costs.

With ACA repeal and replace on the horizon, digital healthcare solutions will surely be affected.

What should managed care executives know about the GOP ACA replacement plan? Find out.

ACA repeal or replacement must focus on how to preserve mental health services and pharmacy access.

Industry leaders share their go-to strategies.

Seven ways health execs can prepare for the future.

While Trump has touted Obamacare as a “disaster,” some healthcare experts say the change could negatively impact hospitals in a variety of ways.

Health plans of the future will focus on consumers: designing products, care and services to support improved health.

New treatment indications are under investigation for the use of cannabinoid-based drugs. Are you ready?

Republicans recently unveiled their ACA replacement plan. Here’s what the experts say you need to know.

Health insurance has served different purposes over the years. It may be time to rethink today’s system.

Will Trump’s policies hamper or improve healthcare access? Experts weigh in.

Allegheny Health Network (AHN) in Pittsburgh, Pennsylvania, has achieved what few health systems have been able to do-offer same-day specialty appointments across its hospital network.

Here’s how experts say the blocked Aetna-Humana and Anthem-Cigna mergers will affect consolidation among payers and providers.

Here’s what a Vizient’s hospital leader survey says about the future of the Affordable Care Act (ACA) and other healthcare policies under the new Administration.

SCOTUS nominee Judge Neil Gorsuch could have an impact on healthcare. Here’s how.

Commonwealth Fund’s 2016 Biennial Health Insurance Survey found significant improvements in people’s ability to buy health plans on their own after implementation of the ACA insurance reforms.

A new report highlights the top states most affected by repeal of the ACA. Is your state among the top 10?

In order to survive as a managed care organization, it’s important to stay on top of policy changes and reimbursement trends.

As Donald Trump was sworn in as the 45th U.S. president, health policy experts share with Managed Healthcare Executive what’s next for healthcare.

As the destiny of Obamacare takes center stage, two researchers have proposed the next-generation of HSAs-HDHPs, a new way to design health insurance plans that could win bipartisan support.

Care for the poor and sick is costly; someone has to pay for it.

Decisions of the U.S. Supreme Court can have a huge impact on the healthcare industry. This year is no different.

Experts discuss how managed healthcare executives might benefit from the ACA repeal and other healthcare reforms.

A repeal of key provisions of the health law could lead to significant economic disruption and substantial job losses in every state, according to a new study.

Experts discuss four of the biggest concerns managed healthcare executives have about repealing the ACA.